123dkk
-4,7 %
Date:2024-12-20Time:16:59:36Latest report:Q4-2023List:SpotlightTicker:CSMED
Market Cap:18 mdkkEnterprise Value:27 mdkkNet Sales:1,07 mdkkEarnings:-14,5 mdkkEmployees:0ISIN:DK0061668225

Ratios

10-year key figure history for CS Medica turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for CS Medica with index and moving average MA50 and MA200.

Stockprice:1,23
MA50:4,33
MA200:5,07
Price/MA200:-75,5 %
RSI (14):21,6
Price/MA50:-71,4 %

Description

CS MEDICA is a Danish-based medical company, exploring and harnessing the potential of compounds found in the Cannabis sativa L. plant. The Company operates within the medical and cosmetic industries, focusing on pain treatment across Europe. CS MEDICA was founded in 2011 and has its headquarters in Copenhagen, Denmark. The Company runs its business through two fully-owned subsidiaries, Galaxa Pharma A/S, based in Greve, Denmark, and CanNordic A/S, based in Copenhagen, Denmark.

Pharmaceuticals